Current Clinical Trials

Roche/Genentech

Palmetto Retina - Wednesday, March 21, 2018
BOULEVARD-BP30099: A multiple-center, multiple-dose, randomized, active comparator−controlled, double-masked, parallel group, 28-week study to investigate the safety, tolerability, pharmacok Read More

TREX DME-ML28724

Palmetto Retina - Thursday, July 24, 2014
Sponsor: Genentech A phase I/II, open-label, multicenter, randomized, controlled study of the safety, tolerability and efficacy of intravitreal injections of 0.3 mg ranibizumab given monthly c Read More

Protocol M

Palmetto Retina - Thursday, July 24, 2014
Sponsor: JAEB Center for Health Research-DRCR Effects of Diabetes Education during Retinal Ophthalmology Visits on Diabetes Control Read More

Protocol T

Palmetto Retina - Thursday, July 24, 2014
Sponsor: JAEB Center for Health Research-DRCR A Comparative Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Read More

VGFT-OD-1009.01 (VISTA)

Palmetto Retina - Thursday, July 24, 2014
Sponsor: Regeneron Title: A Double-Masked, Randomized, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Intravitreal Administration of VEGF Trap-Eye in Patients with Diabetic Mac Read More

Diabetic Retinopathy 2011-Present

Palmetto Retina - Tuesday, September 10, 2013
Diabetic Retinopathy Clinical Research Network: Effect of Diabetes Education during Retinal Ophthalmology Visits on Diabetes Control. Protocol M Read More

0

Combined Years of Practice

0

Operations Performed

0

Clinical Trials Participated

0

Offices

Our Physicians

Take a few moments to meet the skilled physicians of Palmetto Retina, P.A.

Please Contact Us For More Information

(803) 931-0077 | (888) 931-0077